Subsequently, we found that DTX2 promoted the secretion of CXCL2 and CXCL6 from HCC cells to recruit neutrophils and polarize them toward a protumor phenotype, thus attenuating the proliferation and cytotoxicity of CD8+ T cells. The gene discussed is CD8A; the disease is hepatocellular carcinoma.